You are here: Home » News-IANS » Health-Medicine
Business Standard

First human oesophagus created in lab using stem cells

Health Medical Pharma

IANS  |  New York 

In a first, US scientists have used stem cells to grow human oesophagus -- known as the food pipe -- in the laboratory, an advance that will enable personalised disease diagnosis, regenerative therapies.

A team from the Cincinnati Children's Hospital in Ohio successfully generated fully formed human oesophageal organoids -- tiny version of an organ produced in vitro in three dimensions -- using pluripotent stem cells (PSCs).

PSCs are master cells that can potentially produce any cell or tissue the body needs to repair itself.

The oesophageal organoids grew to a length of about 300-800 micrometers in about two months.

"Disorders of the oesophagus and trachea are prevalent enough in people that organoid models of human oesophagus could be greatly beneficial," said lead investigator Jim Wells, from the hospital.

"In addition to being a new model to study birth defects like oesophageal atresia, the organoids can be used to study diseases like oeosinophilic oesophagitis and Barrett's metaplasia, or to bioengineer genetically matched oesophageal tissue for individual patients," he added.

In the study, published in the journal Cell Stem Cell, the team focused on the gene Sox2 and its associated protein -- known to trigger oesophageal conditions when their function is disrupted.

The scientists used mice, frogs and human tissue cultures to identify other genes and molecular pathways regulated by Sox2 during oesophagus formation.

During critical stages of embryonic development, the Sox2 gene blocks the programming and action of genetic pathways that direct cells to become respiratory instead of oesophageal.

The Sox2 protein inhibits the signalling of a molecule called Wnt and promotes the formation and survival of oesophageal tissues.

Conversely, the absence of Sox2 during the development process in mice can result in oesophageal agenesis -- a condition in which the oesophagus terminates in a pouch and does not connect to the stomach.

Those tests showed the bioengineered and biopsies tissues were strikingly similar in composition, the team said.

Cincinnati Children's scientists have previously used PSCs to bioengineer human intestine, stomach, colon and liver.



(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Fri, September 21 2018. 17:32 IST